Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
Abstract Background Pancreatic cancer is one of the most lethal type of cancers, with an overall five-year survival rate of less than 5%. It is usually diagnosed at an advanced stage with limited therapeutic options. To date, no effective treatment options have demonstrated long-term benefits in adv...
Main Authors: | Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli, Chun-Wai Mai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1153-8 |
Similar Items
-
Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
by: Li-Lian Gan, et al.
Published: (2020-07-01) -
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
by: Ying Li, et al.
Published: (2023-03-01) -
S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study
by: Weiwei Hao, et al.
Published: (2023-10-01) -
Pancreatic cancer microenvironment: a current dilemma
by: Burak Uzunparmak, et al.
Published: (2019-01-01) -
Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer
by: Yiyi Liang, et al.
Published: (2021-07-01)